Pitavastatin effects on lipids in relation to major adverse cardiovascular events: a REPRIEVE secondary analysis

By afschroeder • April 6, 2026

Umbleja T, Zafar MU, McCallum S, Gattu AK, Zanni MV, Bloomfield GS, Malvestutto CD, Fichtenbaum CJ, Currier JS, Sponseller CA, Diggs MR, Chu SM, Lu AB, Glesby MJ, Stapleton JT, Frank M, Nguyen KL, Bender Ignacio RA, Han WM, Douglas PS, Aberg JA, Ribaudo HJ, Grinspoon SK. Pitavastatin effects on lipids in relation to major adverse cardiovascular events: a REPRIEVE secondary analysis. Lancet HIV. 2026 Apr 2:S2352-3018(26)00031-7. doi: 10.1016/S2352-3018(26)00031-7. Epub ahead of print. PMID: 41936375.

Tags: Cardiology/Epi, Infectious Diseases, Publications, Veterans Administration

Trends and Disparities in Aortic Stenosis and Coronary Artery Disease-Related Mortality Among U.S. Adults Aged ≥65 Years, 1999-2024

Daniyal SM, Sarwar M, Fahim SL, Khatoon NM, Noor A, Batool F, Riaz M, Ajaz H, Gondal HT, Aftab Z, Gul I, Fonarow GC. Trends[...]

Comparison of Inpatient End-of-Life Care Intensity Between Heart Failure and Cancer

Halloran S, Meng Z, Harap R, Baldridge A, Wilcox J, Rao A, Adaboh A, Fonarow GC, Allen LA, Tibrewala A, Chuzi S. Comparison of Inpatient[...]

Interhospital Transfer for Heart Failure in the United States: A Patient and Hospital-level Analysis from GWTG-HF

Rudofker EW, Ayodele I, Fonarow GC, Hess PL, Oldemeyer JB, Ho PM, Peterson PN, Maddox KEJ, Chiswell K, Greene SJ, Allen LA. Interhospital Transfer for[...]